New drug shows promise for bulging eyes in thyroid disease
NCT ID NCT06126783
First seen May 05, 2026 · Last updated May 14, 2026 · Updated 3 times
Summary
This study looked at how well and how safely the drug IBI311 works for people with thyroid eye disease (TED). It included 91 adults who had already completed a previous study on IBI311. The main goal was to see if the drug could reduce eye bulging by at least 2 millimeters without making the other eye worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE (TED) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.